Life science in Stockholm

Sweden has the fourth-largest biotech market in Europe. More than half of its biotechnology enterprise, some 460 companies, is located in the Stockholm region.

New member to Active board

The Election Committee of Active Biotech proposes a very experienced financial sector executive to join the company board. Five existing members are also to be ...

Polymer guru new dean at DTU

The Technical University of Denmark, DTU, has appointed a well-known profile from the Polymer Center as a new dean.

New CEO to Medivir

The Board of the Swedish biotech company Medivir has appointed the successor to the current CEO Lars Adlersson.

Finnish-Dutch engineering cooperation continues

The University of Helsinki and ASM International renew a fice year research agreement on Atomic Layer Deposition.

EU grants project on toxicity of nanomaterials

A multinational research project has have been awarded EUR 3 358 500 from the European Commission to study the hazardous effects of engineered nanomaterials on ...

Trögt för medtech

En svag tillväxt, färre men större förvärv och rekordmånga börsnoteringar är några av fynden i konsultbolaget EY:s årliga sammanställning av medtechbranschen.

Focusing on Medicon Valley

Copenhagen Capacity and Invest in Skåne are hosting a seminar to promote the geographical area known as Medicon Valley. Some of the 350 life science companies f...

A platform for dialogue

As a step towards connecting the life science industry in Denmark, Biologue was founded three years ago with 10 member companies. Today, the network has 40 memb...

We are poor lobbyists

I doubt there has ever been a really well thought out Scandinavian campaign with intentions to really change attitudes among both the public and politicians.

Pfizer lays a chunky bid on Wyeth

The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at app...

Parnevik firm in Swiss osteoporosis deal

The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.

Bäst effekt om datorn får bestämma

Individanpassade läkemedel helt utvecklade i datorn, det är en verklighet som kan vara sann om tio år, tror Jens Nielsen, professor i systembiologi på Chalmers i Göteborg.

Viktigt välja rätt bolagsnamn

Life science-branschen är generellt sett sämre än andra sektorer på att namnge sina bolag enligt Mats Dafnäs, varumärkesstrateg på kommunikationsbyrån Zellout.

LEO Pharma - International Clinical Trial Manager

Glucose facilitates the use of indigo

The Finnish researcher Anne Vuorema oat the MTT Agrifood Research Finland proves in her new doctoral dissertation that glucose can serve as a reducing agent of indigo.

The winner of the race

She learned how to work hard at an early age and her devotion has certainly paid off. Whether it is field running or running a company, the key to success is fo...

Regelkrångel hindrar industrin

42 procent av läkemedelsindustrin menar att regler och restriktioner är det största hotet mot framgångar på den svenska läkemedelsmarknaden.

Life science mer jämställt

19 procent kvinnor i ledningsgrupperna hos de största life science-företagen.

FDA förordar svensk analysteknik

Melamin i läkemedel ska spåras med en metod som har utvecklats av Umeåföretaget Merck Sequant. - Det här beslutet kommer definitivt ha en positiv inverkan på vå...

De får Forska och Väx-pengar

59 företag får dela på 66 miljoner kronor i senaste Vinnova-utdelningen. 20 är life science-företag.

Förändringsprocessen i läkemedelsindustrin har bara börjat

Läkemedelsindustrins glansdagar tog slut 1996. Hela branschen står inför stora utmaningar och processerna fram till ett nytt läkemedel kommer att förändras, skr...

Martin Bergö: "The Idea is the Thing"

Martin Bergö, 38, goes wherever ideas take him - it's a process that has led to, and resulted from, plenty of unexpected results. Those ideas have been recogniz...

Festo AB